Wei Wang
Investigator
Dr. Wang received his PhD and MD from the University of Virginia, followed by residency training in internal medicine at the Hospital of the University of Pennsylvania and a fellowship in medical oncology at the Fred Hutchinson Cancer Research Center/University of Washington. His early research career focused on tumor immunology and antigen presentation, resulting in multiple high-impact publications in journals such as Science, PNAS, Journal of Immunology, and Cancer Research.
Clinically, Dr. Wang specializes in breast cancer, melanoma, and hereditary cancer risk, with extensive experience as a principal investigator on Phase II clinical trials involving targeted therapies, immunotherapy, and combination regimens. He is actively involved in clinical research, teaching, and mentoring medical students and residents, and has played leadership roles within institutional cancer committees and professional oncology organizations. Dr. Wang remains committed to integrating cutting-edge research with compassionate, patient-centered cancer care.